| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.074 | 0.1 |